| 106 |
NAD+ repletion with niacin counteracts cancer cachexia
|
김선욱 |
22 |
2023-08-15 |
|
| 105 |
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
|
성현지 |
18 |
2023-07-28 |
|
| 104 |
TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma
|
장은미 |
28 |
2023-07-03 |
|
| 103 |
Eda2r nik signaling pathway in muscle wasting
|
Kim Hyun Jun |
38 |
2023-06-21 |
|
| 102 |
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles
|
김선욱 |
275 |
2023-05-16 |
|
| 101 |
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy
|
이상훈 |
50 |
2023-05-10 |
|
| 100 |
GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia
|
성현지 |
24 |
2023-05-10 |
|
| 99 |
PROX1 tranxss-scription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets
|
장은미 |
54 |
2023-04-07 |
|
| 98 |
The myokine Fibcd1 is an endogeneous determinant of myofiber size and mitigates cancer induced myofiber atrophy
|
Kim Hyun Jun |
48 |
2023-03-21 |
|
| 97 |
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
|
성현지 |
56 |
2023-03-15 |
|
